The smarter Ozempic alternative.

Compounded semaglutide is not the same as Ozempic® and is not a generic version of it. Ozempic® is an FDA-approved finished drug product manufactured by Novo Nordisk. Compounded semaglutide is a non-FDA-approved preparation containing the peptide semaglutide, prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review risks, benefits, and considerations with you before prescribing.

Brand-name Ozempic includes manufacturer marketing, distribution markups, and brand premium. Compounded semaglutide is prepared directly by a state-licensed compounding pharmacy under an individual prescription, which removes those layers. We pass the savings to patients without changing the level of clinical oversight by your licensed provider.

Compounded medications are not FDA-approved finished drug products. They are prepared under the 503A or 503B regulatory framework by state-licensed compounding pharmacies and are subject to USP standards. REMEVi only partners with state-licensed compounding pharmacies, and every patient is evaluated by a licensed provider before any medication is dispensed. Your provider will review risks, benefits, and contraindications with you before prescribing.

No. You do not need a previous Ozempic prescription to start with REMEVi. During your intake, you can share any prior GLP-1 experience (dose, side effects, results), and your licensed provider will use that information to design your personalized protocol.